Hemodilution with albumin, but not Hextend®, results in hypercoagulability as assessed by Thrombelastography® in rabbits: Role of heparin-dependent serpins and factor VIII complex

Andrew T. McCammon, Jonathan P. Wright, Mario Figueroa, Vance G. Nielsen

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Isovolemic hemodilution (IVHD) has been advocated as an effective method of reducing the need for transfusion but has been associated with hypercoagulability. We tested the hypothesis that IVHD enhances hemostatic function by decreasing circulating antithrombin activity in rabbits. Furthermore, it was determined whether different replacement solutions would affect hemostasis. Sedated rabbits were randomly assigned to groups that underwent IVHD (40% blood volume removed) with 5% human albumin (n = 10) or a 6% hetastarch solution (Hextend®). Antithrombin and Factor VIII complex (VIII:C) activities were determined, and thrombelastography® was performed with or without platelet inhibition. IVHD resulted in a significant (P < 0.05) decrease in antithrombin (32%-39%) without fluid-specific differences observed. VIII:C did not change in the albumin group, whereas the hetastarch group had a significant (P < 0.05) decrease (43%) in VIII:C that was also significantly (P < 0.05) less than the albumin group. The time to clot initiation was decreased, and the rate of clot formation increased significantly via thrombelastography® in albumin animals. No significant change in clot kinetics was observed in hetastarch animals. In rabbits, the primary determinant of hemostasis after IVHD was the interaction of changes in antithrombin activity and VIII:C. These data serve as a rational basis to determine whether IVHD-mediated hypercoagulability encountered clinically may be attenuated or exacerbated by the choice of colloid administered.

Original languageEnglish (US)
Pages (from-to)844-850
Number of pages7
JournalAnesthesia and Analgesia
Volume95
Issue number4
StatePublished - Oct 2002
Externally publishedYes

Fingerprint

Thrombelastography
Serpins
Hemodilution
Thrombophilia
Factor VIII
Heparin
Albumins
Antithrombins
Hydroxyethyl Starch Derivatives
Rabbits
Hemostasis
Colloids
Hemostatics
Blood Volume
Blood Platelets

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Cite this

Hemodilution with albumin, but not Hextend®, results in hypercoagulability as assessed by Thrombelastography® in rabbits : Role of heparin-dependent serpins and factor VIII complex. / McCammon, Andrew T.; Wright, Jonathan P.; Figueroa, Mario; Nielsen, Vance G.

In: Anesthesia and Analgesia, Vol. 95, No. 4, 10.2002, p. 844-850.

Research output: Contribution to journalArticle

@article{89c75488321a4fe591d6e67ab71c5fbf,
title = "Hemodilution with albumin, but not Hextend{\circledR}, results in hypercoagulability as assessed by Thrombelastography{\circledR} in rabbits: Role of heparin-dependent serpins and factor VIII complex",
abstract = "Isovolemic hemodilution (IVHD) has been advocated as an effective method of reducing the need for transfusion but has been associated with hypercoagulability. We tested the hypothesis that IVHD enhances hemostatic function by decreasing circulating antithrombin activity in rabbits. Furthermore, it was determined whether different replacement solutions would affect hemostasis. Sedated rabbits were randomly assigned to groups that underwent IVHD (40{\%} blood volume removed) with 5{\%} human albumin (n = 10) or a 6{\%} hetastarch solution (Hextend{\circledR}). Antithrombin and Factor VIII complex (VIII:C) activities were determined, and thrombelastography{\circledR} was performed with or without platelet inhibition. IVHD resulted in a significant (P < 0.05) decrease in antithrombin (32{\%}-39{\%}) without fluid-specific differences observed. VIII:C did not change in the albumin group, whereas the hetastarch group had a significant (P < 0.05) decrease (43{\%}) in VIII:C that was also significantly (P < 0.05) less than the albumin group. The time to clot initiation was decreased, and the rate of clot formation increased significantly via thrombelastography{\circledR} in albumin animals. No significant change in clot kinetics was observed in hetastarch animals. In rabbits, the primary determinant of hemostasis after IVHD was the interaction of changes in antithrombin activity and VIII:C. These data serve as a rational basis to determine whether IVHD-mediated hypercoagulability encountered clinically may be attenuated or exacerbated by the choice of colloid administered.",
author = "McCammon, {Andrew T.} and Wright, {Jonathan P.} and Mario Figueroa and Nielsen, {Vance G.}",
year = "2002",
month = "10",
language = "English (US)",
volume = "95",
pages = "844--850",
journal = "Anesthesia and Analgesia",
issn = "0003-2999",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Hemodilution with albumin, but not Hextend®, results in hypercoagulability as assessed by Thrombelastography® in rabbits

T2 - Role of heparin-dependent serpins and factor VIII complex

AU - McCammon, Andrew T.

AU - Wright, Jonathan P.

AU - Figueroa, Mario

AU - Nielsen, Vance G.

PY - 2002/10

Y1 - 2002/10

N2 - Isovolemic hemodilution (IVHD) has been advocated as an effective method of reducing the need for transfusion but has been associated with hypercoagulability. We tested the hypothesis that IVHD enhances hemostatic function by decreasing circulating antithrombin activity in rabbits. Furthermore, it was determined whether different replacement solutions would affect hemostasis. Sedated rabbits were randomly assigned to groups that underwent IVHD (40% blood volume removed) with 5% human albumin (n = 10) or a 6% hetastarch solution (Hextend®). Antithrombin and Factor VIII complex (VIII:C) activities were determined, and thrombelastography® was performed with or without platelet inhibition. IVHD resulted in a significant (P < 0.05) decrease in antithrombin (32%-39%) without fluid-specific differences observed. VIII:C did not change in the albumin group, whereas the hetastarch group had a significant (P < 0.05) decrease (43%) in VIII:C that was also significantly (P < 0.05) less than the albumin group. The time to clot initiation was decreased, and the rate of clot formation increased significantly via thrombelastography® in albumin animals. No significant change in clot kinetics was observed in hetastarch animals. In rabbits, the primary determinant of hemostasis after IVHD was the interaction of changes in antithrombin activity and VIII:C. These data serve as a rational basis to determine whether IVHD-mediated hypercoagulability encountered clinically may be attenuated or exacerbated by the choice of colloid administered.

AB - Isovolemic hemodilution (IVHD) has been advocated as an effective method of reducing the need for transfusion but has been associated with hypercoagulability. We tested the hypothesis that IVHD enhances hemostatic function by decreasing circulating antithrombin activity in rabbits. Furthermore, it was determined whether different replacement solutions would affect hemostasis. Sedated rabbits were randomly assigned to groups that underwent IVHD (40% blood volume removed) with 5% human albumin (n = 10) or a 6% hetastarch solution (Hextend®). Antithrombin and Factor VIII complex (VIII:C) activities were determined, and thrombelastography® was performed with or without platelet inhibition. IVHD resulted in a significant (P < 0.05) decrease in antithrombin (32%-39%) without fluid-specific differences observed. VIII:C did not change in the albumin group, whereas the hetastarch group had a significant (P < 0.05) decrease (43%) in VIII:C that was also significantly (P < 0.05) less than the albumin group. The time to clot initiation was decreased, and the rate of clot formation increased significantly via thrombelastography® in albumin animals. No significant change in clot kinetics was observed in hetastarch animals. In rabbits, the primary determinant of hemostasis after IVHD was the interaction of changes in antithrombin activity and VIII:C. These data serve as a rational basis to determine whether IVHD-mediated hypercoagulability encountered clinically may be attenuated or exacerbated by the choice of colloid administered.

UR - http://www.scopus.com/inward/record.url?scp=0036784722&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036784722&partnerID=8YFLogxK

M3 - Article

C2 - 12351255

AN - SCOPUS:0036784722

VL - 95

SP - 844

EP - 850

JO - Anesthesia and Analgesia

JF - Anesthesia and Analgesia

SN - 0003-2999

IS - 4

ER -